The RUSH University Cancer Center Biorepository was founded in 2004 to support researchers at RUSH who are leading innovative cancer research by getting the patient specimens they need for their research. Our team partners with researchers and major academic medical centers across the country, as well as industry and the National Cancer Institute, to advance cancer research that ultimately affects patient care.
If you would like to discuss your support of the Molecular Mechanisms in Cancer and Cancer Biorepository Research Fund, please contact Charles Palys, Director of Development, at charles_palys@rush.edu or he can be reached via phone at (312) 563-9059. You have many options for giving vehicles, multi-year commitments, and other opportunities to impact The RUCC Biorepository and/or Dr. Borgia’s research.